Insulin Glargine (U-100) Cartridge Systems and Pens and Zofran ODT
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Zofran ODT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ondansetron
Brand name: Zofran, Zofran ODT, Zuplenz
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Zofran ODT Oral, Oromucosal
- Insulin Glargine (U-100) Cartridge Systems and Pens-Zofran Oral, Oromucosal
- Insulin Glargine (U-100) Cartridge Systems and Pens-Zohydro ER
- Insulin Glargine (U-100) Cartridge Systems and Pens-Zohydro ER Capsules
- Insulin Glargine (U-100) Cartridge Systems and Pens-Zoladex
- Insulin Glargine (U-100) Cartridge Systems and Pens-Zoladex (Goserelin Implant 10.8 mg)
- Zofran ODT-Insulin Glargine (U-100) Vials
- Zofran ODT-Insulin Glargine (U-300) Pens
- Zofran ODT-Insulin glargine and lixisenatide
- Zofran ODT-Insulin glargine and lixisenatide Subcutaneous
- Zofran ODT-Insulin glargine, recombinant Subcutaneous
- Zofran ODT-Insulin glulisine